{"transactions":[{"id":875172,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-03-02T22:58:22.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2221,"price":73.9,"value":164131.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":74916,"source":{"system":"sec-edgar","filing":"0001871002-26-000006","document":"wk-form4_1772492300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000006/wk-form4_1772492300.xml","form_type":"4"}},{"id":875171,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-03-02T22:58:22.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":11116,"price":77.15,"value":857599.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":77137,"source":{"system":"sec-edgar","filing":"0001871002-26-000006","document":"wk-form4_1772492300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000006/wk-form4_1772492300.xml","form_type":"4"}},{"id":902014,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-02-17T21:05:51.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1717,"price":77.36,"value":132827.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,355 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":66021,"source":{"system":"sec-edgar","filing":"0001871002-26-000004","document":"wk-form4_1771362348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000004/wk-form4_1771362348.xml","form_type":"4"}},{"id":902013,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-02-17T21:05:51.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1608,"price":76.7,"value":123333.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,590 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":67738,"source":{"system":"sec-edgar","filing":"0001871002-26-000004","document":"wk-form4_1771362348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000004/wk-form4_1771362348.xml","form_type":"4"}},{"id":905864,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-02-13T21:12:08.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4269,"price":76.25,"value":325511.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":69346,"source":{"system":"sec-edgar","filing":"0001871002-26-000002","document":"wk-form4_1771017125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000002/wk-form4_1771017125.xml","form_type":"4"}},{"id":999329,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2025-11-14T21:30:18.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":94,"price":88,"value":8272.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":158490,"source":{"system":"sec-edgar","filing":"0001871002-25-000007","document":"wk-form4_1763155816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100225000007/wk-form4_1763155816.xml","form_type":"4"}},{"id":999328,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2025-11-14T21:30:18.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":14642,"price":89.07,"value":1304162.94,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $89.00 to $89.50. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":158584,"source":{"system":"sec-edgar","filing":"0001871002-25-000007","document":"wk-form4_1763155816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100225000007/wk-form4_1763155816.xml","form_type":"4"}},{"id":1064495,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2025-08-18T20:29:10.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":86.97,"value":1739400.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $86.54 to $88.05. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":173226,"source":{"system":"sec-edgar","filing":"0001871002-25-000004","document":"wk-form4_1755548946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100225000004/wk-form4_1755548946.xml","form_type":"4"}},{"id":1264815,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2025-02-19T01:14:05.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":9574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":73615,"source":{"system":"sec-edgar","filing":"0001871002-25-000002","document":"wk-form4_1739927639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100225000002/wk-form4_1739927639.xml","form_type":"4"}},{"id":1264814,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2025-02-19T01:14:05.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":14362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025."}],"balance_after":64041,"source":{"system":"sec-edgar","filing":"0001871002-25-000002","document":"wk-form4_1739927639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100225000002/wk-form4_1739927639.xml","form_type":"4"}},{"id":1463999,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-07-03T00:58:43.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":63.44,"value":1268800.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $62.81 to $64.11. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":193226,"source":{"system":"sec-edgar","filing":"0001871002-24-000014","document":"wk-form4_1719968317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100224000014/wk-form4_1719968317.xml","form_type":"4"}},{"id":1493367,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-06-04T22:08:03.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":64.41,"value":1288200.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $63.35 to $65.40. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":213226,"source":{"system":"sec-edgar","filing":"0001871002-24-000012","document":"wk-form4_1717538875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100224000012/wk-form4_1717538875.xml","form_type":"4"}},{"id":1529122,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-05-03T21:48:16.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":66.62,"value":1332400.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $66.05 to $67.30. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":233226,"source":{"system":"sec-edgar","filing":"0001871002-24-000010","document":"wk-form4_1714772885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100224000010/wk-form4_1714772885.xml","form_type":"4"}},{"id":1554548,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-04-02T22:59:16.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":67.25,"value":1345000.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $66.50 to $69.05. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":253226,"source":{"system":"sec-edgar","filing":"0001871002-24-000008","document":"wk-form4_1712098747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100224000008/wk-form4_1712098747.xml","form_type":"4"}},{"id":1579357,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-03-13T20:44:44.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":65.81,"value":1316200.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $65.23 to $66.34. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":273226,"source":{"system":"sec-edgar","filing":"0001871002-24-000006","document":"wk-form4_1710362669.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100224000006/wk-form4_1710362669.xml","form_type":"4"}},{"id":1608049,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-03-01T22:01:47.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1635,"price":67.67,"value":110640.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":49679,"source":{"system":"sec-edgar","filing":"0001871002-24-000004","document":"wk-form4_1709330494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100224000004/wk-form4_1709330494.xml","form_type":"4"}},{"id":1639211,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-02-16T21:34:46.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":8946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":51314,"source":{"system":"sec-edgar","filing":"0001871002-24-000002","document":"wk-form4_1708119272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100224000002/wk-form4_1708119272.xml","form_type":"4"}},{"id":1639210,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-02-16T21:34:46.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":13421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024."}],"balance_after":42368,"source":{"system":"sec-edgar","filing":"0001871002-24-000002","document":"wk-form4_1708119272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100224000002/wk-form4_1708119272.xml","form_type":"4"}},{"id":1768656,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2023-10-04T00:00:20.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":56.48,"value":1129600.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of sales on October 2, 2023. The shares were sold in multiple transactions at prices ranging from $55.90 to $57.66, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":293226,"source":{"system":"sec-edgar","filing":"0001871002-23-000009","document":"wk-form4_1696377605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100223000009/wk-form4_1696377605.xml","form_type":"4"}},{"id":1789800,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2023-09-05T21:06:01.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":64.7,"value":1294000.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of sales on September 1, 2023. The shares were sold in multiple transactions at prices ranging from $64.18 to $65.26, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":313226,"source":{"system":"sec-edgar","filing":"0001871002-23-000006","document":"wk-form4_1693947949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100223000006/wk-form4_1693947949.xml","form_type":"4"}},{"id":1816934,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2023-08-03T22:03:26.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":51.06,"value":1021200.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of sales on August 1, 2023. The shares were sold in multiple transactions at prices ranging from $50.52 to $52.33, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":333226,"source":{"system":"sec-edgar","filing":"0001871002-23-000004","document":"wk-form4_1691100197.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100223000004/wk-form4_1691100197.xml","form_type":"4"}},{"id":1834336,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2023-07-06T20:15:33.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":53.43,"value":1068600.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of sales on July 3, 2023. The shares were sold in multiple transactions at prices ranging from $52.76 to $54.10, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":353226,"source":{"system":"sec-edgar","filing":"0001104659-23-078742","document":"tm2320740-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923078742/tm2320740-1_4seq1.xml","form_type":"4"}},{"id":1845654,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2023-06-24T00:00:34.000Z","date":"2023-06-22","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":51.32,"value":1026400.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":373226,"source":{"system":"sec-edgar","filing":"0001104659-23-074398","document":"tm2319615-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923074398/tm2319615-1_4seq1.xml","form_type":"4"}},{"id":1929757,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2023-04-05T00:03:10.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":11578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":28947,"source":{"system":"sec-edgar","filing":"0001104659-23-041729","document":"tm2311710-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041729/tm2311710-4_4seq1.xml","form_type":"4"}},{"id":1929756,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2023-04-05T00:03:10.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":17369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023."}],"balance_after":17369,"source":{"system":"sec-edgar","filing":"0001104659-23-041729","document":"tm2311710-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041729/tm2311710-4_4seq1.xml","form_type":"4"}},{"id":2322099,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2022-03-22T21:37:55.000Z","date":"2022-03-21","kind":"purchase","acquired":true,"shares":5000,"price":27.8685,"value":139342.5,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were acquired in multiple trades at prices ranging from $27.69 to $28.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":393226,"source":{"system":"sec-edgar","filing":"0001415889-22-003267","document":"form4-03222022_020338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003267/form4-03222022_020338.xml","form_type":"4"}},{"id":2322098,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2022-03-22T21:37:55.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":5000,"price":27.1488,"value":135744.0,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired in multiple trades at prices ranging from $27.06 to $27.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":388226,"source":{"system":"sec-edgar","filing":"0001415889-22-003267","document":"form4-03222022_020338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003267/form4-03222022_020338.xml","form_type":"4"}},{"id":2499179,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2021-11-23T21:44:43.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":383226,"ownership":{"direct":false,"nature":"Held by Chali Properties LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 19, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of March 8, 2021 (as amended, supplemented or modified from time to time, the \"Merger Agreement\"), by and among ANI Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\"), Novitium Pharma LLC, a Delaware limited liability company (\"Novitium\"), and the other parties thereto, the Issuer completed its acquisition of Novitium.  In accordance with the Merger Agreement, an aggregate of 2,000,000 Company Interests of Novitium held by Chali Properties LLC were converted into 383,226 shares of Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person holds voting and dispositive power over the shares held by Chali Properties LLC."}],"balance_after":383226,"source":{"system":"sec-edgar","filing":"0001415889-21-005442","document":"form4-11232021_011133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921005442/form4-11232021_011133.xml","form_type":"4"}}]}